As Fosamax Bone Fracture Lawsuits Pile Up, Merck Seeks Consolidation
An increasing number of women have filed Fosamax lawsuits claiming the popular osteoporosis drug caused them to suffer a rare type of femur, or thigh, fracture. Merck & Co., the maker of Fosamax,...
View ArticleFosamax Thigh Fractures, Other Side Effects May Accompany Long-Term Use
Taking Fosamax, the popular osteoporosis treatment used by millions of women, for too long may do serious damage to the bones it is supposed to protect. Debilitating Fosamax side effects may include...
View ArticleFracture Risk Prompts Experts to Recommend Bisphosphonate Changes
Experts are recommending that doctors change the way they prescribe bisphosphonates like Fosamax, in light of recent research indicating the osteoporosis drugs may be associated with serious thigh...
View ArticleConsolidation Ordered for Fosamax Fracture Lawsuits
More than three dozen lawsuits alleging the osteoporosis drug Fosamax caused plaintiffs to suffer low-impact femur fractures have been consolidated in a mulitdistrict litigation and transferred to the...
View ArticleHawaiian Woman Claims Using Fosamax Led to Thigh Fracture
A woman in Hawaii has filed suit against Merck & Co. for an injury she claims was the result of taking Fosamax. Lois Takamori, who began taking Fosamax in her 50s to prevent bone loss from...
View ArticleFDA Panel to Discuss Bisphosphonate Side Effects in September
A Food & Drug Administration (FDA) advisory panel is set to discuss the safety issues surrounding bone drugs like Actonel, Boniva and Fosamax on September 9. According to a report from Dow Jones...
View ArticleFive Years on Fosamax, Other Bone Drugs May be Adequate, FDA Says
Fosamax, Actonel, Boniva and other oral bisphosphonates don’t have to be taken beyond five years in order to prevent broken bones from osteoporosis, a new U.S. Food & Drug Administration (FDA)...
View ArticleFosamax, Other Osteoporosis Drugs Need Stronger Warnings, FDA Advisors Say
A panel of Food & Drug Administration (FDA) advisors said on Friday that Fosamax and similar bone drugs need stronger warnings regarding duration of use because of their possible long-term risks....
View ArticleFosamax Femur Fracture Theory Questioned by Researchers
A case study published late last month in the New England Journal of Medicine (NEJM) is raising questions about one theory that tries to account for the higher femur fracture risk seen among users of...
View ArticleLawsuits Allege Women Suffered Fosamax Femur Fractures
Recent lawsuits allege that women have suffered Fosamax femur fractures. Fosamax is a bisphosphonate and, more and more, research supports a link between atypical fractures of the femur, generally...
View ArticleNational Law Firm Files 36 Fosamax Femur Fracture Lawsuits
Earlier this month, the national law firm of Parker Waichman LLP filed 36 Fosamax femur fracture lawsuits in the Fosamax side effects mass tort currently underway in New Jersey Superior Court. All of...
View ArticleEye Disorders Another Possible Bisphosphonate Side Effect
Fosamax and other bisphosphonates used by millions of women to prevent osteoporosis may make it more likely that they will suffer anterior uveitis and scleritis, serious inflammatory eye disorders....
View ArticleFDA Bisphosphonate Study Finds Few Benefits from Long-Term Use
A new U.S. Food & Drug Administration (FDA) analysis is raising serious concerns about the long-term use of bisphosphonates like Fosamax to treat weak bones. While the bisphosphonate analysis found...
View ArticleBisphosphonate Study Confirms Atypical Thigh Fracture Risk
New research has confirmed the link between bisphoshonates, such as Fosamax, and atypical femur fractures, a type of thigh fracture that occurs spontaneously, without any major leg injury. The study,...
View ArticleMississippi Woman Alleges Use of Fosamax Led to Femur Fracture
Another woman has filed a lawsuit alleging that her use of Fosamax (alendronate) led to a left femur fracture and other complications. The lawsuit, filed on behalf of the Mississippi woman by national...
View ArticleIndiana Woman Files Fosamax Lawsuit Following Pair of Femur Fractures
An Indiana woman claims taking the bisphosphonate drug Fosamax caused her to suffer fractures to her left and right femur bones. She has become the latest to file a lawsuit against the manufacturers of...
View ArticleMaryland Woman Claims Fosamax Caused Fractures in Both Thighs
Yet another woman has filed a lawsuit claiming that Merck’s Fosamax (alendronate) caused fractures to her legs. In the Maryland woman’s case, she suffered double thigh fractures. According to the...
View ArticleSouth Carolina Women Files Fosamax Femur Fracture Lawsuit
Another woman just filed a lawsuit against the maker of Fosamax (alendronate) over a femur fracture she suffered while on the osteoporosis medication. The South Carolina woman is being represented by...
View ArticleSettlement Reached in Fosamax Dead Jaw Syndrome Lawsuit
A confidential settlement on damages has been reported in a Fosamax lawsuit brought by the estate of a Florida woman who developed Osteonecrosis of the Jaw (ON J or Dead Jaw Syndrome) while taking the...
View ArticleBisphosphonate drugs Fosamax, Boniva not right for women in “pre-menopause”
Women suffering from osteopenia, often referred to as pre-menopause, should avoid taking bisphosphonate drugs like Fosamax to prevent bone loss in most circumstances. Consumer Reports magazine’s team...
View ArticleWoman who suffered jawbone loss due to Fosamax reaches damages settlement...
A woman who claims her taking Fosamax in the prevention of bone loss caused by osteoporosis resulted in her developing decay of her jaw bone has reached a confidential settlement with the makers of the...
View ArticleMerck Readying for 2nd Round of New Jersey Fosamax Lawsuits
Drug maker, Merck & Company will be facing its second round of Fosamax (alendronate) lawsuits in New Jersey over allegations that the bone drug causes femur fractures. Jury selections is set to...
View ArticleHalted Fosamax Trial Re-Scheduled
We recently wrote that drug maker, Merck & Company, was scheduled to face its second round of Fosamax (alendronate) lawsuits in New Jersey over allegations that the bone drug causes femur...
View ArticleSecond Fosamax Femur Injury Trial Underway
Merck & Company, the maker of Fosamax (alendronate), is facing a second of thousands of cases brought by plaintiffs who allege they suffered Fosamax injuries. The first lawsuit recently ended in a...
View ArticleFosamax Lawsuit Begins with Opening Remarks
Opening arguments today signaled the start of the second trial charging Merck’s Fosamax with causing femur fractures. In New Jersey federal court the focus was on the case of 58-year-old Bernadette...
View ArticleOpening Statements Heard in Second Fosamax Femur Fracture Trial
The second Fosamax femur fracture trial is underway and involve allegations that Merck’s Fosamax (alendronate) caused femur fractures in some people. The trial began in New Jersey federal court and...
View ArticleJudge Overrules Merck’s Bid to Boot Expert Testimony from Four Doctors in...
Merck and Co. was unable to stop doctors from giving expert testimony during the New Jersey-based trial, now under way, regarding osteoporosis drug Fosamax for allegedly causing atypical femur...
View ArticleBisphosphonate Use Linked to Barrett’s Esophagus
A study published last month in the American Journal of Gastroenterology suggests that oral bisphosphonate use was associated with a 2.33 percent increased risk of Barretts’ esophagus, a condition that...
View ArticleJudge Denies Merck’s Request to Force Fosamax Plaintiffs To Verify Injuries
This week, a New York federal judge denied a request to mandate hundreds of alleged Fosamax victims to substantiate their injuries. Fosamax is manufactured by Merck & Co. U.S. District Judge John...
View ArticleHundreds of Fosamax Lawsuits Being Sent to Trial
A federal judge just ordered hundreds of cases involved in a multidistrict litigation (MDL) brought against Merck & Co. over alleged Fosamax jaw injuries be sent for trial in courts nationwide....
View ArticleMerck Cutting Staff Over Research Unit Re-Structure Plans
Drug giant, Merck, has announced plans to cut 8,500 employees as part of a restructuring meant to increase marketplace competitiveness. Over the next two years, in addition to the massive layoffs,...
View ArticleJudge Delays Fosamax MDL “Wind-Down”
To enable plaintiffs and Merck & Co. Inc. time to work on a potential settlement, a New York federal judge delayed the transfer of hundreds of lawsuits that are part of a multidistrict litigation...
View ArticleBisphosphonates Associated with Increased Risk of Atypical Hip Fractures,...
The use of bisphosphonates, drugs prescribed to prevent hip fractures in women with osteoporosis, is associated with an increased risk of atypical fractures in this joint. The research is contained in...
View Article
